3 ms·
The "Subject 1" and "Subject 2" sections of the paper both speak of persistent malignancy in bone marrow.
by maxerickson 10y ago
The "Subject 1" and "Subject 2" sections of the paper both speak of persistent malignancy in bone marrow.
- strainer 10y agoI have not the experience to read this report with any confidence, but your comments are so far too brief to convince me that you have. Fig 2 in the report includes a chart which appears to indicate a bone marrow reading clearing in response to application of allo-SCT. How do you ascertain that this treatment does not in itself improve malignancy in bone marrow?
- maxerickson 10y agoThese “off-the-shelf” CAR T cells were then used to treat two infants with relapsed refractory acute lymphocytic leukemia and bridge them to allogeneic stem cell transplantation. I don't have much knowledge of the subject but a stem cell/bone marrow transplant seems to be a common treatment in aggressive cases of leukemia.